InvestorsHub Logo
Followers 75
Posts 5498
Boards Moderated 0
Alias Born 10/19/2006

Re: None

Saturday, 12/08/2018 10:46:50 PM

Saturday, December 08, 2018 10:46:50 PM

Post# of 1954
Here's Why Madrigal Pharmaceuticals Fell 39.4% in November

......Unfortunately for Madrigal, Viking Therapeutics (NASDAQ: VKTX) presented results from a midstage trial with another experimental TRB agonist that's a little further back on the development timeline. Treatment with VK2809 helped NAFLD patients reduce their liver fat content by 59%, which appears to wipe the floor with results from MGL-3196.......

https://finance.yahoo.com/news/apos-why-madrigal-pharmaceuticals-fell-200300888.html

GO VKTX

"PEACE"
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VKTX News